Mucosal immunization with integrase-defective lentiviral vectors protects against influenza virus challenge in mice.
Ontology highlight
ABSTRACT: Recent reports highlight the potential for integrase-defective lentiviral vectors (IDLV) to be developed as vaccines due to their ability to elicit cell-mediated and humoral immune responses after intramuscular administration. Differently from their integrase-competent counterpart, whose utility for vaccine development is limited by the potential for insertional mutagenesis, IDLV possess a mutation in their integrase gene that prevents genomic integration. Instead, they are maintained as episomal DNA circles that retain the ability to stably express functional proteins. Despite their favorable profile, it is unknown whether IDLV elicit immune responses after intranasal administration, a route that could be advantageous in the case of infection with a respiratory agent. Using influenza as a
SUBMITTER: Fontana JM
PROVIDER: S-EPMC4019533 | biostudies-literature | 2014
REPOSITORIES: biostudies-literature
ACCESS DATA